Literature DB >> 2535808

Physiological concentrations of atrial natriuretic factors with intact N-terminal sequences inhibit corticotropin-releasing factor-stimulated adrenocorticotropin secretion from cultured anterior pituitary cells.

M S King1, A J Baertschi.   

Abstract

The effectiveness of atrial natriuretic factors (ANFs) as inhibitors of CRF-stimulated ACTH secretion was examined in cultured rat anterior pituitary cells. alpha ANF-(1-28) significantly inhibited ACTH release stimulated by 1-5 nM CRF. At the most effective concentration of 100 pM, alpha ANF-(1-28) inhibited ACTH release by 40.1% (P less than 0.001). This effect was manifested after 3 h, but not after 0.5 or 1 h, of incubation, suggesting that ACTH synthesis may have been reduced. Conversely, alpha ANF-(5-28), at concentrations of 10 pM to 10 nM, had no effect on ACTH secretion after 0.5, 1, or 3 h. alpha ANF-(1-11) weakly inhibited ACTH secretion at concentrations of 100 and 1000 pM. Again, these effects were observed after 3 h, but not after 0.5 or 1 h, of incubation. These results suggest that ANF-induced inhibition of CRF-stimulated ACTH release requires 1) an intact N-terminal sequence of the ANF peptide, 2) low concentrations, and 3) more than 1 h of incubation. The results explain previous negative evidence and suggest that alpha ANF-(1-28) may be a physiological inhibitor of ACTH secretion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535808     DOI: 10.1210/endo-124-1-286

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Intracerebroventricular administration of atrial natriuretic peptide prevents increase of plasma ADH, aldosterone and corticosterone levels in restrained conscious dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; S Bountzioukas; K Mavroudis; M Karamouzis; O Guiba-Tziampiri
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

Review 2.  Towards a functional significance of peptides and biogenic amines produced by the anterior pituitary.

Authors:  H Houben; D Tilemans; C Denef
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

3.  Effects of intracerebroventricular administration of atrial natriuretic peptide (ANP) on blood pressure, heart rate and plasma ADH and corticosterone levels in normal and dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; M Apostolakis; S Bountzioukas; O Guiba-Tziampiri; H Kontoleon-Vakalopoulou; K Mavroudis
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

4.  Corticotropin-releasing hormone causes antidiuresis and antinatriuresis by stimulating vasopressin and inhibiting atrial natriuretic peptide release in male rats.

Authors:  J Gutkowska; M Jankowski; S Mukaddam-Daher; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 5.  The role of intracellular messengers in adrenocorticotropin secretion in vitro.

Authors:  M S King; A J Baertschi
Journal:  Experientia       Date:  1990-01-15

6.  Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administration.

Authors:  A Colao; R Pivonello; D Ferone; G La Tessa; A Faggiano; G Facciolli; C Di Somma; B Merola; G Lombardi
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.